Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Sunitinib, in Subject With Refractory Solid Tumors [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the safety and efficacy of sunitinib in patients with refractory solid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Sunitinib (sunitinib)

Snippet

Sponsor: Samsung Medical Center | Conditions: Refractory Solid Tumors | Phase 4 | Status: COMPLETED